Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 21, 2013; 19(47): 9012-9019
Published online Dec 21, 2013. doi: 10.3748/wjg.v19.i47.9012
Published online Dec 21, 2013. doi: 10.3748/wjg.v19.i47.9012
Figure 5 Second malignancies occurred in 472 of 2821 patients with gastroenteropancreatic neuroendocrine tumor.
A: The absolute number; B: The percentage of patients with one or more second (non-gastroenteropancreatic neuroendocrine tumor, non-GEP-NET) neoplasms. 0 = No second neoplasm. GEP-NET: Gastroenteropancreatic neuroendocrine tumor.
- Citation: Scherübl H, Streller B, Stabenow R, Herbst H, Höpfner M, Schwertner C, Steinberg J, Eick J, Ring W, Tiwari K, Zappe SM. Clinically detected gastroenteropancreatic neuroendocrine tumors are on the rise: Epidemiological changes in Germany. World J Gastroenterol 2013; 19(47): 9012-9019
- URL: https://www.wjgnet.com/1007-9327/full/v19/i47/9012.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i47.9012